← Back to Clinical Trials
Recruiting NCT05729802

The Holographic Standardized Patient

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Medical Emergencies
Sponsor Sunnybrook Health Sciences Centre
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 20 Years
Max Age 100 Years
Start Date 2023-03-01
Completion 2025-09-01
Interventions
HoloSIM Software via Hololens 2Training by Mannequin Based Simulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The current pandemic has revealed in-person simulation training and evaluation is vulnerable to disruption, and alternatives are needed which allow remote evaluation. The recently developed Microsoft Hololens headset device allows interactable holograms to be inserted into a user's workspace (mixed reality) - permitting the augmentation of existing clinical and training spaces with holographic (i.e. virtual) patients via the prototype HoloSIM software. This study is the first known research initiative aiming to demonstrate the feasibility and effectiveness of mixed reality for acute medicine training and assessment at a distance. Space, time, personnel, pandemic, and cost constraints limit opportunities for high-fidelity simulation exercises for post-graduate trainees at Sunnybrook. By developing and demonstrating the effectiveness of this new training modality, increased simulation exercises will lead to a higher quality education experience, better functioning teams, and better patient outcomes.

Eligibility Criteria

Inclusion Criteria: * Resident or fellow level volunteers from acute care postgraduate training programs (Internal Medicine, Emergency Medicine, Anesthesiology, Critical Care Medicine at Sunnybrook Health Sciences Centre Exclusion Criteria: * Unwilling to enter the study * Previous experience with simulator based teaching on anaphylaxis

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}